- Home
- KMPR vs ADMA Comparison
KMPR vs ADMA Comparison
Compare KMPR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMPR
- ADMA
- Stock Information
- Founded
- KMPR 1990
- ADMA 2004
- Country
- KMPR United States
- ADMA United States
- Employees
- KMPR N/A
- ADMA N/A
- Industry
- KMPR Property-Casualty Insurers
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KMPR Finance
- ADMA Health Care
- Exchange
- KMPR Nasdaq
- ADMA Nasdaq
- Market Cap
- KMPR 4.2B
- ADMA 4.1B
- IPO Year
- KMPR N/A
- ADMA N/A
- Fundamental
- Price
- KMPR $56.71
- ADMA $21.31
- Analyst Decision
- KMPR Strong Buy
- ADMA Strong Buy
- Analyst Count
- KMPR 4
- ADMA 4
- Target Price
- KMPR $81.00
- ADMA $22.50
- AVG Volume (30 Days)
- KMPR 615.8K
- ADMA 3.7M
- Earning Date
- KMPR 04-30-2025
- ADMA 05-08-2025
- Dividend Yield
- KMPR 2.26%
- ADMA N/A
- EPS Growth
- KMPR N/A
- ADMA N/A
- EPS
- KMPR 4.91
- ADMA 0.81
- Revenue
- KMPR $4,639,200,000.00
- ADMA $426,454,000.00
- Revenue This Year
- KMPR $9.33
- ADMA $18.45
- Revenue Next Year
- KMPR $11.79
- ADMA $26.96
- P/E Ratio
- KMPR $11.55
- ADMA $26.31
- Revenue Growth
- KMPR N/A
- ADMA 65.16
- 52 Week Low
- KMPR $53.57
- ADMA $6.01
- 52 Week High
- KMPR $73.01
- ADMA $23.64
- Technical
- Relative Strength Index (RSI)
- KMPR 34.08
- ADMA 60.16
- Support Level
- KMPR $56.11
- ADMA $17.30
- Resistance Level
- KMPR $59.27
- ADMA $22.25
- Average True Range (ATR)
- KMPR 2.69
- ADMA 1.50
- MACD
- KMPR -0.51
- ADMA 0.16
- Stochastic Oscillator
- KMPR 21.70
- ADMA 83.62
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.